L-2-oxothiazolidine-4-carboxylate: An agent that modulates lipopolysaccharide-induced peritonitis in rats

Peritoneal Dialysis International

Volumn 22, Issue 3, 2002, Pages 293-300

  Korybalska, Katarzyna ^a   Wieczorowska Tobis, Katarzyna ^a   Polubinska, Alicja ^a   Wisniewska, Justyna ^a   Moberly, James ^a   Martis, Leo ^a   Breborowicz, Andrzej ^a   Oreopoulos, Dimitrios G ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

L 2 oxothiazolidine 4 carboxylate (OTZ); Lipopolysaccharide induced peritonitis; Rat

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; DIANEAL; GLUTATHIONE; LIPOPOLYSACCHARIDE;

ANTIOXIDANT ACTIVITY; CELL COUNT; CELL MEMBRANE PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIALYSATE; DRUG EFFECT; FUNCTION TEST; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; RAT; REVIEW; ULTRAFILTRATION;

EID: 0036587049     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080202200301     Document Type: Review

References (32)

1. Pollock CA, Ibels LS, Hallett MD, Cocksedge B, Caterson RJ, Mahony JF, et al. Loss of ultrafiltration in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9:107-10.
2. Verger C, Lugar A, Moore HL, Nolph KD. Acute changes in peritoneal morphology and transport properties with infectious and mechanical injury. Kidney Int 1983; 23:823-31.
3. Dobbie JW. Ultrastructure and pathology of the peritoneum in peritoneal dialysis. In: Gokal R, Nolph KD, eds. The Textbook of Peritoneal Dialysis. Dordrecht: Kluwer Academic; 1994:69-113.
4. Babior BM. Oxygen dependent microbacterial killing by phagocytes (first of two parts). N Engl J Med 1978; 298:659-68.
5. Farber JL, Kyle ME, Coleman JB. Mechanism of cell injury by activated oxygen species. Lab Invest 1990; 62:670-9.
6. McBride TJ, Preston BD, Loeb LA. Mutagenic spectrum resulting from DNA damage by oxygen radicals. Biochemistry 1992; 30:207-13.
7. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 1988; 263:17205-8.
8. Deneke SM, Lynch BA, Fanburg BL. Transient depletion of lung glutathione by diethylmaleate enhances oxygen toxicity. J Appl Physiol 1985; 58:571-4.
9. Breborowicz A, Patrikarea A, Martis L, Oreopoulos DG. L-2-Oxothiazolidine-4-carboxylate and N-acetylcysteine as precursors of intracellular glutathione in human peritolneal mesothelial cells. Blood Purif 1996; 14:1-7.
10. Olney JW, Ho OL. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 1970; 227:609-11.
11. Nath KA, Salabudeen AK. Autooxidation of cysteine generates hydrogen peroxide: cytotoxicity and attenuation by pyruvate. Am J Physiol 1993; 264:F306-14.
12. Issels RD, Nagele A, Erkert KG, Wilmanns W. Promotion of cysteine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. Biochem Pharmacol 1988; 37:881-8.
13. Williamson JM, Meister A. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. Proc Natl Acad Sci USA 1981; 78:936-9.
14. Barditch-Crovo P, Noe D, Skowron G, Lederman M, Kalayjian RC, Borum P, et al. A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus. J Clin Pharmacol 1998; 38:357-63.
15. Moberly JB, Logan J, Borum. PR, Story KO, Webb LE, Jassal SV, et al. Elevation of whole blood glutathione in peritoneal dialysis patients by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug (procysteine). J Am Soc Nephrol 1998; 9: 1093-9.
16. Breborowicz A, Rodela H, Martis L, Oreopoulos DG. Intracellular glutathione in human peritoneal mesothelial cells exposed in vitro to dialysis fluid. Int J Artif Organs 1996; 19:268-75.
17. Blair SL, Rose D, Sachar S, Burt ME. Oral L-2-oxothiazolidine-4-carboxylate reduces bacterial translocation after radiation in the Fisher rats. J Surg Res 1996; 65:165-8.
18. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russel JA, et al. A trial of antioxidants N-acetylcysteine and procysteine in ARSD. Chest 1997; 112:164-72.
19. Wieczorowska-Tobis K, Korybalska K, Polubinska A, Radkowski M, Breborowicz A. In vivo model to study the biocompatibility of peritoneal dialysis solutions. Int J Artif Organs 1997; 20:673-7.
20. Tietze F. Enzymic method for quantitative determination of nanograin amounts of total and oxidized glutathione. Anal Biochem 1969; 27:502-22.
21. Lowry OH, Rosebrough NJ, Lewis-Farr A, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
22. Holmes CJ. Biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1993; 13:88-94.
23. Phelps DT, Ferro TJ, Higgins PJ, Shankar R, Parker DM, Johnson A. TNF-α induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 1995; 269:L551-9.
24. Poon BY, Goddard CM, Leaf CD, Russell JA, Walley KR. L-2-Oxothiazolidine-4-carboxylic acid prevents endotoxin-induced cardiac dysfunction. Am J Respir Crit Care Med 1998; 158:1109-13.
25. Marcho Z, White JE, Higgins PJ, Tsan MF. Tumor necrosis factor enhances endothelial cell susceptibility to oxygen toxicity: role of glutathione. Am J Respir Cell Mol Biol 1991; 5:556-62.
26. Ross EA, Koo LC, Moberly JB. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1997; 30:489-94.
27. Pena LR, Hill DB, McLain CJ. Treatment with glutathione precursor decreases cytokine activity. JPEN J Parenter Enteral Nutr 1999; 23:1-6.
28. Sato M, Miazaki T, Nagaya T, Murata M, Ida N, Maeda K, et al. Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1 and collagenase expression in cultured human synovial cells. J Rheumatol 1996; 23:432-8.
29. Das SK, White AC, Fanburg BL. Modulation of transforming growth factor-β1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine. J Clin Invest 1992; 90:1649-56.
30. Rahman I, MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol 1999; 277:L1067-88.
31. Suzuki K, Khanna R, Nolph KD, Moore HL, Twardowski ZJ. Spontaneous peritonitis and peritoneal fibrosis in rats on peritoneal dialysis for 9 weeks. Adv Perit Dial 1995; 11:52-6.
32. Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S, Freeman BA. Tumor necrosis factor and interleukin-1 increase vascular endothelial permeability. Am J Physiol 1989; 257: L399-410.